NCT07317778 2026-01-05
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
Clinical Trials
1 trialsBreast Cancer Early Stage Breast Cancer (Stage 1-3) × Immune Checkpoint Inhibitors × 90 days × Clear all